Protein
Protein
Enhance productivity and purity in next-generation bispecific antibody manufacturing
07-14-2025 / Dr. Heng Tai Liew, Senior Protein Scientist, GenScript Biotech
In this webinar, we will introduce GenScript’s TurboCHOTM technology, which addresses these challenges through an integrated and iterative workflow that optimizes cell lines, vectors, and media using Design of Experiments (DOE) to fine-tune chain ratios a
Learn More Protein
Webinar: mRNA & Protein Technologies in Diagnostics and Therapeutics | GenScript
04-29-2025 / Dr. Alvin Chew, Dr. Yuxiao Liu, Dr. Christian Nefzger, Associate Professor Jason Lee
Join GenScript's expert-led webinar on April 29, 2025, to explore cutting-edge mRNA and protein technologies driving innovation in diagnostics, vaccines, and disease management. Register now!
Learn More Protein
AI-based Antibody Therapeutics Developability Assessment and Its Engineering
02-27-2025 / Dr. Carter Hao, Senior Bioinformatics Scientist
In this webinar, we are excited to present our Immunoinformatics Comprehensive Service Platform, which leverages AI for the developability assessment of antibody therapeutics.
Learn More Protein
Transforming Medicine: The Potential of Endothelial Cilia Proteins as Groundbreaking Biomarkers
12-13-2024 / Ramani Ramchandran, PhD | Professor, Medical College of Wisconsin President and Founder, CIAN, Inc
Cilia are microtubule-based organelles found in most cells in the body. Endothelial cilia are a known blood flow sensor and studies have identified that upon high shear stress, endothelial cilia get dismantled, a process called deciliation.
Learn More Protein
Protein
Enhancing Treatments using Targeted Protein Degradation | GenScript
01-11-2024 / Dr. Yongheng Huang, Doctor in Biochemistry, Protein Senior Scientist, GenScript
Join this webinar to gain insights into targeted protein degradation (TPD) and ubiquitin-proteasomal degradation (UPD) and learn new avenues for enhanced treatment efficacy through selective protein removal.
Learn More Protein
Adaptive Immune Response in Narcolepsy Type 1
10-06-2023 / Dr. Guo Luo, Immunologist and Instructor, Stanford University School of Medicine
Join this webinar to learn about the adaptive immune response in narcolepsy type 1 (NT1), including peptide binding affinity to human leukocyte antigen (HLA), the isolation of antigen-HLA restricted CD4+ T cells, and single-cell RNA sequencing of CD4+ T c
Learn More